Synthesis and antifungal activity of new N-(1-phenyl-4-carbetoxypyrazol-5-yl)-, N-(indazol-3-yl)- and N-(indazol-5-yl)-2-iodobenzamides
摘要:
N-(1-Phenyl-4-carbetoxypyrazol-5-yl)-, N-(indazol-3-yl)- and N-(indazol-5-yl)-2-iodobenzamides 6, with a Benodanil-like structure, were synthesized by refluxing in acetic acid the corresponding benzotriazin ones 5 with potassium iodide for 1 h in order to study the role on the antifungal activity of the N-substitution with an aromatic heterocyclic system on benzamide moiety. Among the tested iododerivatives, compounds 6d,f,g,h possess interesting activities toward some phytopathogenic fungal strains. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
Synthesis and antifungal activity of new N-(1-phenyl-4-carbetoxypyrazol-5-yl)-, N-(indazol-3-yl)- and N-(indazol-5-yl)-2-iodobenzamides
摘要:
N-(1-Phenyl-4-carbetoxypyrazol-5-yl)-, N-(indazol-3-yl)- and N-(indazol-5-yl)-2-iodobenzamides 6, with a Benodanil-like structure, were synthesized by refluxing in acetic acid the corresponding benzotriazin ones 5 with potassium iodide for 1 h in order to study the role on the antifungal activity of the N-substitution with an aromatic heterocyclic system on benzamide moiety. Among the tested iododerivatives, compounds 6d,f,g,h possess interesting activities toward some phytopathogenic fungal strains. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
Anthranilic acid amides and the use thereof as medicaments
申请人:Schering AG
公开号:US07122547B1
公开(公告)日:2006-10-17
The invention relates to anthranilic acid amides and the use thereof as medicaments for the treatment of diseases that are triggered by persistent angiogenesis, in addition to intermediate products in the production of anthranilic acid amides.
本发明涉及到蒽酰胺及其作为治疗由持续血管生成引起的疾病的药物,以及在蒽酰胺的生产中的中间体产品。
ANTHRANILSÄUREAMIDE UND DEREN VERWENDUNG ALS ARZNEIMITTEL
申请人:SCHERING AKTIENGESELLSCHAFT
公开号:EP1129074A2
公开(公告)日:2001-09-05
US7122547B1
申请人:——
公开号:US7122547B1
公开(公告)日:2006-10-17
[DE] ANTHRANILSÄUREAMIDE UND DEREN VERWENDUNG ALS ARZNEIMITTEL<br/>[EN] ANTRHRANILIC ACID AMIDES AND THE USE THEREOF AS MEDICAMENTS<br/>[FR] AMIDES D'ACIDE ANTHRANILIQUE ET LEUR UTILISATION COMME MEDICAMENT
申请人:SCHERING AG
公开号:WO2000027819A2
公开(公告)日:2000-05-18
Es werden Anthranilsäureamide und deren Verwendung als Arzneimittel zur Behandlung von Erkrankungen, die durch persistente Angiogenese ausgelöst werden, sowie deren Zwischenprodukte zur Herstellung der Anthranilsäureamide beschrieben.
Synthesis and antifungal activity of new N-(1-phenyl-4-carbetoxypyrazol-5-yl)-, N-(indazol-3-yl)- and N-(indazol-5-yl)-2-iodobenzamides
N-(1-Phenyl-4-carbetoxypyrazol-5-yl)-, N-(indazol-3-yl)- and N-(indazol-5-yl)-2-iodobenzamides 6, with a Benodanil-like structure, were synthesized by refluxing in acetic acid the corresponding benzotriazin ones 5 with potassium iodide for 1 h in order to study the role on the antifungal activity of the N-substitution with an aromatic heterocyclic system on benzamide moiety. Among the tested iododerivatives, compounds 6d,f,g,h possess interesting activities toward some phytopathogenic fungal strains. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.